IL10 and non-Hodgkin lymphoma: It is important to note that DLBCL tumor subtype had overall reduced plasma levels of PD-L1+ EVs compared to the Burkitt’s NHL subgroup, raising the possibility that the positive and significant association between PD-L1+ EVs and plasma levels of IL-10 is due to tumor type.